X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (996) 996
hygiene (996) 996
medical or veterinary science (996) 996
preparations for medical, dental, or toilet purposes (996) 996
chemistry (972) 972
peptides (972) 972
metallurgy (970) 970
organic chemistry (969) 969
beer (742) 742
biochemistry (742) 742
enzymology (742) 742
microbiology (742) 742
mutation or genetic engineering (742) 742
spirits (742) 742
vinegar (742) 742
wine (742) 742
compositions thereof (735) 735
culture media (735) 735
microorganisms or enzymes (735) 735
propagating, preserving or maintaining microorganisms (735) 735
physics (445) 445
investigating or analysing materials by determining theirchemical or physical properties (432) 432
measuring (432) 432
testing (432) 432
specific therapeutic activity of chemical compounds ormedicinal preparations (345) 345
compositions or test papers therefor (340) 340
condition-responsive control in microbiological orenzymological processes (340) 340
measuring or testing processes involving enzymes, nucleicacids or microorganisms (340) 340
processes of preparing such compositions (340) 340
enzymes (120) 120
devices for introducing media into, or onto, the body (77) 77
devices for producing or ending sleep or stupor (77) 77
devices for transducing body media or for taking media fromthe body (77) 77
general tagging of cross-sectional technologies spanning over several sections of the ipc (68) 68
general tagging of new technological developments (68) 68
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (68) 68
technologies for adaptation to climate change (68) 68
technologies or applications for mitigation or adaptation againstclimate change (68) 68
fermentation or enzyme-using processes to synthesise a desiredchemical compound or composition or to separate optical isomersfrom a racemic mixture (67) 67
information and communication technology [ict] specially adaptedfor specific application fields (64) 64
humans (26) 26
calculating (17) 17
computing (17) 17
counting (17) 17
electric digital data processing (17) 17
index medicus (15) 15
cancer (12) 12
nucleotides (12) 12
derivatives thereof (11) 11
nucleic acids (11) 11
nucleosides (11) 11
sugars (11) 11
immunotherapy (9) 9
oncology (9) 9
animals (8) 8
proteins (8) 8
expression (7) 7
immunology (7) 7
ligands (7) 7
lymphocytes (7) 7
multidisciplinary sciences (7) 7
antigens (6) 6
antigens, neoplasm - immunology (6) 6
biochemistry & molecular biology (6) 6
carcinoma, renal cell - immunology (6) 6
cd8-positive t-lymphocytes - immunology (6) 6
female (6) 6
identification (6) 6
kidney neoplasms - immunology (6) 6
male (6) 6
mice (6) 6
research (6) 6
vitamin d (6) 6
antigen (5) 5
epitopes, t-lymphocyte - immunology (5) 5
gene expression (5) 5
glioblastoma (5) 5
health aspects (5) 5
mass spectrometry (5) 5
mutation (5) 5
oligonucleotide array sequence analysis (5) 5
peptides - immunology (5) 5
peptides - metabolism (5) 5
studies (5) 5
25-hydroxyvitamin d (4) 4
alfacalcidol (4) 4
analysis (4) 4
antigen presentation - immunology (4) 4
association (4) 4
calcifediol (4) 4
cell line, tumor (4) 4
clinical medicine (4) 4
colony-stimulating factor (4) 4
endocrinology (4) 4
gene expression profiling (4) 4
health (4) 4
histocompatibility antigen hla (4) 4
histocompatibility antigens class ii - immunology (4) 4
hla antigens - immunology (4) 4
in-vitro (4) 4
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (918) 918
French (184) 184
Spanish (153) 153
German (87) 87
Chinese (72) 72
Korean (36) 36
Portuguese (32) 32
Hungarian (12) 12
Japanese (12) 12
Russian (11) 11
Slovenian (11) 11
Croatian (10) 10
Danish (10) 10
Serbian (10) 10
Polish (8) 8
Lithuanian (6) 6
Greek (5) 5
Ukrainian (5) 5
Turkish (3) 3
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature Medicine, ISSN 1078-8956, 08/2012, Volume 18, Issue 8, pp. 1254 - 1261
IMA901 is the first therapeutic vaccine for renal cell cancer (RCC) consisting of multiple tumor-associated peptides (TUMAPs) confirmed to be naturally... 
MEDICINE, RESEARCH & EXPERIMENTAL | PULSED DENDRITIC CELLS | COLONY-STIMULATING FACTOR | HIGH-FREQUENCIES | BIOCHEMISTRY & MOLECULAR BIOLOGY | MELANOMA PATIENTS | RENAL-CELL CARCINOMA | TUMOR-ANTIGEN | CELL BIOLOGY | MYELOID SUPPRESSOR-CELLS | PROSTATE-CANCER | REGULATORY T-CELLS | PEPTIDE VACCINE | Predictive Value of Tests | Cyclophosphamide - administration & dosage | Prognosis | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Kidney Neoplasms - immunology | Immunotherapy, Active | Male | Lymphocyte Depletion | Granulocyte-Macrophage Colony-Stimulating Factor - therapeutic use | Carcinoma, Renal Cell - immunology | Cyclophosphamide - therapeutic use | Kidney Neoplasms - blood | T-Lymphocytes, Regulatory - immunology | Cancer Vaccines - therapeutic use | Vaccines, Subunit - therapeutic use | Female | Carcinoma, Renal Cell - drug therapy | Immunosuppressive Agents - pharmacology | Chemokine CCL17 - blood | Immunosuppressive Agents - administration & dosage | Kidney Neoplasms - therapy | Carcinoma, Renal Cell - blood | HLA-A2 Antigen - immunology | Antigens, Neoplasm - immunology | Kaplan-Meier Estimate | Treatment Outcome | Combined Modality Therapy | T-Lymphocytes, Regulatory - drug effects | Cyclophosphamide - pharmacology | Biomarkers | Carcinoma, Renal Cell - therapy | CD8-Positive T-Lymphocytes - immunology | Kidney Neoplasms - drug therapy | Apolipoprotein A-I - blood | Cancer vaccines | Cyclophosphamide | Polypeptides | Immune response | Dosage and administration | Research | Health aspects | Kidney diseases | Peptides | Gene expression | Medical prognosis | Cancer | Immune system
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2005, Volume 102, Issue 22, pp. 7922 - 7927
Journal Article
Nature, ISSN 0028-0836, 01/2019, Volume 565, Issue 7738, pp. 240 - 245
Journal Article
Nature Communications, ISSN 2041-1723, 12/2018, Volume 9, Issue 1, pp. 3919 - 10
Journal Article
Neurosurgery, ISSN 0148-396X, 09/2019, Volume 66, Issue Supplement_1
Abstract INTRODUCTION Diffuse infiltrating low-grade gliomas (WHO grade II and III) are slow-growing primary brain tumors, but considered malignant due to... 
Journal Article
Brain, ISSN 0006-8950, 2012, Volume 135, Issue 4, pp. 1042 - 1054
Peptides presented at the cell surface reflect the protein content of the cell; those on HLA class I molecules comprise the critical peptidome elements... 
peptidome | glioblastoma | tumour-infiltrating lymphocytes | tumour antigen | immunotherapy | AVIDITY | IDENTIFICATION | NEUROSCIENCES | CLINICAL NEUROLOGY | GLIOMA-CELL | GROWTH | CHONDROITIN SULFATE PROTEOGLYCAN | SELECTION | EXPRESSION | T-CELLS | PROGRESSION | TENASCIN-C | Oligonucleotide Array Sequence Analysis | Humans | Brain Neoplasms - pathology | Gene Expression Profiling | Glial Fibrillary Acidic Protein - metabolism | RNA, Messenger - metabolism | Antigens, Neoplasm - chemistry | HLA-A Antigens - analysis | Antigens, CD - metabolism | Sequence Analysis, Protein | Brain Neoplasms - immunology | Flow Cytometry | Antigens, Neoplasm - therapeutic use | Platelet Endothelial Cell Adhesion Molecule-1 - metabolism | Mass Spectrometry | Chromatography, Liquid | Cytokines - metabolism | Antigens, Neoplasm - immunology | Peptides - immunology | Glioblastoma - therapy | HLA-A Antigens - immunology | Glioblastoma - immunology | Glioblastoma - pathology | Brain Neoplasms - therapy | HLA-A Antigens - chemistry | CD8-Positive T-Lymphocytes - immunology | Antigen Presentation - physiology | Peptides - analysis | Receptor-Like Protein Tyrosine Phosphatases, Class 5 - metabolism | Immunogenicity | CD8 antigen | Immunotherapy | Glioblastoma | Data processing | Histocompatibility antigen HLA | Lymphocytes T | Vaccines | Cell surface | Immunological tolerance
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 03/2005, Volume 11, Issue 5, pp. 1928 - 1940
Dendritic cells are the most powerful antigen-presenting cells playing a decisive role for the initiation and maintenance of primary immune responses. However,... 
c-Abl | Glivec | T cell activation | RelB | CHRONIC MYELOGENOUS LEUKEMIA | IN-VITRO | ACTIVATED RECEPTOR-GAMMA | COLONY-STIMULATING FACTOR | ONCOLOGY | ABL TYROSINE KINASE | BCR-ABL | NECROSIS-FACTOR-ALPHA | LOW-DOSE CYTARABINE | GASTROINTESTINAL STROMAL TUMORS | CHRONIC MYELOID-LEUKEMIA
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 2/2013, Volume 111, Issue 3, pp. 285 - 294
Journal Article
PROTEOMICS, ISSN 1615-9853, 06/2018, Volume 18, Issue 12, pp. e1700284 - n/a
Journal Article